The cost to taxpayers could be enormous.Sales growth of Zepbound in the U.S. has been constrained by rules that bar Medicare, ...

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...

Maridebart cafraglutide, a novel injectable GIP receptor antagonist/GLP-1 receptor agonist, reduced body weight by ...

Doctors have long told how they are treating increasing numbers of Brits who end up in hospital after providing false ...

Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...

Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

If you’ve been holding off on joining a weight loss program because you’re apprehensive about the cost, you’ll be glad to ...

Soon after her husband Uwe died in the summer of 2015, Unislim managing director Fiona Gratzer began experiencing intense and ...

Novo Nordisk faces scrutiny over UK pharmacy sponsorships tied to weight-loss drugs, with critics citing conflicts of interest and regulatory breaches.

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.